What does moclobemide do and how effective is it?
What does moclobemide do?
Moclobemide is thought to work by changing the amount of the brain chemicals serotonin, noradrenaline and dopamine, which are involved in controlling mood.
Moclobemide is a type of antidepressant called a reversible inhibitor of monoamine oxidase A (RIMA).
How effective is moclobemide?
About 50% of people treated with antidepressants find their depression symptoms are halved.
Although all antidepressants have shown similar efficacy when tested in groups of people in clinical trials, keep in mind that individuals can find one antidepressant works better for them than another. So if the first antidepressant you try doesn’t seem to be working for you after a few weeks, talk to your doctor about switching to another. A psychological therapy, such as cognitive behavioural therapy (CBT), could also be an option.
Find out more about
- Who moclobemide is for and who should be cautious
- Side effects of moclobemide
- Interactions with moclobemide
- Brands of moclobemide
If you are starting moclobemide, see 10 things you should know about antidepressants.
For more information
- Starting, switching and stopping antidepressants
- Managing side effects of antidepressants
- Psychological therapies
The consumer medicine information (CMI) for your brand of moclobemide is available from our website or a pharmacist. The CMI includes:
- How to take this medicine
- What to do if you forget to take it
- If you take too much (overdose)
- Things you must and must not do while taking this medicine
- Signs of severe reactions and what to do.
- Rossi S, ed. eAMH [online]. Adelaide: Australian Medicines Handbook, 2012. www.amh.net.au. (Accessed 9 February 2012).
- Psychotropic Expert Group. Therapeutic Guidelines: Psychotropic, Version 6. In: eTG complete [CD-ROM]. Melbourne: Therapeutic Guidelines Limited; 2008.
- Williams JW Jr, Mulrow CD, Chiquette E, et al. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med 2000;132:743–56. [PubMed]
- Meda Valeant Pharma Australia Pty Limited. Aurorix consumer medicine information. 18 March 2010 (accessed 22 March 2012).
- National Collaborating Centre for Mental Health. Depression: the NICE guideline on the treatment and management of depression in adults (updated edition). London: National Institute for Health and Clinical Excellence, 2010. www.nice.org.uk/nicemedia/live/12329/45896/45896.pdf (accessed 9 February 2012).